[1] |
HERRMAN H, KIELING C, MCGORRY P,et al. Reducing the global burden of depression:a Lancet-World Psychiatric Association Commission[J]. Lancet, 2019, 393(10189):e42-43. DOI: 10.1016/S0140-6736(18)32408-5.
|
[2] |
HUANG Y Q, WANG Y, WANG H,et al. Prevalence of mental disorders in China:a cross-sectional epidemiological study[J]. Lancet Psychiatry, 2019, 6(3):211-224. DOI: 10.1016/S2215-0366(18)30511-X.
|
[3] |
MURPHY J A, SARRIS J, BYRNE G J. A review of the conceptualisation and risk factors associated with treatment-resistant depression[J]. Depress Res Treat, 2017, 2017:4176825. DOI: 10.1155/2017/4176825.
|
[4] |
LEVKOVITZ Y, ISSERLES M, PADBERG F,et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression:a prospective multicenter randomized controlled trial[J]. World Psychiatry, 2015, 14(1):64-73. DOI: 10.1002/wps.20199.
|
[5] |
ROTH Y, PELL G S, CHISTYAKOV A V,et al. Motor cortex activation by H-coil and figure-8 coil at different depths. Combined motor threshold and electric field distribution study[J]. Clin Neurophysiol, 2014, 125(2):336-343. DOI: 10.1016/j.clinph.2013.07.013.
|
[6] |
TENDLER A, BARNEA YGAEL N, ROTH Y,et al. Deep transcranial magnetic stimulation (dTMS) - beyond depression[J]. Expert Rev Med Devices, 2016, 13(10):987-1000. DOI: 10.1080/17434440.2016.1233812.
|
[7] |
CHEN W L, WAGNER J, HEUGEL N,et al. Functional near-infrared spectroscopy and its clinical application in the field of neuroscience:advances and future directions[J]. Front Neurosci, 2020, 14:724. DOI: 10.3389/fnins.2020.00724.
|
[8] |
MARTINI M, ARIAS N. Near-infrared light spectroscopy and stimulation in cognitive neuroscience:the need for an integrative view?[J]. J Integr Neurosci, 2021, 20(4):1105-1109. DOI: 10.31083/j.jin2004111.
|
[9] |
KASTER T S, DASKALAKIS Z J, NODA Y,et al. Efficacy,tolerability,and cognitive effects of deep transcranial magnetic stimulation for late-life depression:a prospective randomized controlled trial[J]. Neuropsychopharmacology, 2018, 43(11):2231-2238. DOI: 10.1038/s41386-018-0121-x.
|
[10] |
MATSUDA Y, KITO S, IGARASHI Y,et al. Efficacy and safety of deep transcranial magnetic stimulation in office workers with treatment-resistant depression:a randomized,double-blind,sham-controlled trial[J]. Neuropsychobiology, 2020, 79(3):208-213. DOI: 10.1159/000505405.
|
[11] |
|
[12] |
LISTON C, CHEN A C, ZEBLEY B D,et al. Default mode network mechanisms of transcranial magnetic stimulation in depression[J]. Biol Psychiatry, 2014, 76(7):517-526. DOI: 10.1016/j.biopsych.2014.01.023.
|
[13] |
LAN M J, CHHETRY B T, LISTON C,et al. Transcranial magnetic stimulation of left dorsolateral prefrontal cortex induces brain morphological changes in regions associated with a treatment resistant major depressive episode:an exploratory analysis[J]. Brain Stimul, 2016, 9(4):577-583. DOI: 10.1016/j.brs.2016.02.011.
|
[14] |
LIMA-OJEDA J M, RUPPRECHT R, BAGHAI T C. Neurobiology of depression:a neurodevelopmental approach[J]. World J Biol Psychiatry, 2018, 19(5):349-359. DOI: 10.1080/15622975.2017.1289240.
|
[15] |
LEVKOVITZ Y, HAREL E V, ROTH Y,et al. Deep transcranial magnetic stimulation over the prefrontal cortex:evaluation of antidepressant and cognitive effects in depressive patients[J]. Brain Stimul, 2009, 2(4):188-200. DOI: 10.1016/j.brs.2009.08.002.
|
[16] |
BAHUN I, IVEZIC E, ĐOGAS V V,et al. A pilot study of accelerated deep transcranial magnetic stimulation effects on cognitive functioning in patients diagnosed with treatment resistant major depressive disorder[J]. Psychiatry Res, 2022, 316:114750. DOI: 10.1016/j.psychres.2022.114750.
|
[17] |
LASKOV O, KLÍROVÁ M. Effects of deep transcranial magnetic stimulation (dTMS) on cognition[J]. Neurosci Lett, 2021, 755:135906. DOI: 10.1016/j.neulet.2021.135906.
|
[18] |
OKADA G, OKAMOTO Y, YAMASHITA H,et al. Attenuated prefrontal activation during a verbal fluency task in remitted major depression[J]. Psychiatry Clin Neurosci, 2009, 63(3):423-425. DOI: 10.1111/j.1440-1819.2009.01952.x.
|
[19] |
TOMIOKA H, YAMAGATA B, KAWASAKI S,et al. A longitudinal functional neuroimaging study in medication-naïve depression after antidepressant treatment[J]. PLoS One, 2015, 10(3):e0120828. DOI: 10.1371/journal.pone.0120828.
|
[20] |
TAKAMIYA A, HIRANO J, EBUCHI Y,et al. High-dose antidepressants affect near-infrared spectroscopy signals:a retrospective study[J]. Neuroimage Clin, 2017, 14:648-655. DOI: 10.1016/j.nicl.2017.02.008.
|
[21] |
KENNEDY S H, KONARSKI J Z, SEGAL Z V,et al. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial[J]. Am J Psychiatry, 2007, 164(5):778-788. DOI: 10.1176/ajp.2007.164.5.778.
|